Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 160 mg, 90-count bottles, Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5814-77.

D-0326-2019

December 04, 2018

Class II

Product summary

Firm
Mylan Laboratories Limited, (Nashik FDF)
Event
Event 81707
Status
Ongoing
Classification
Class II
Quantity
232,180 HDPE bottles
Official record key
drug-enforcement:D-0326-2019

Official wording

Reason: GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Code information: Lot Numbers: 3069019, 3069020, 3069021, 3069022, 3071354, 3071355, 3071357 3079023 3079027 3079028 3079029 3079996 3079997 3079998 3083635 3086715 3086716 3086717 3088623

Distribution pattern: Product was distributed throughout the United States to several major distributors, including Puerto Rico.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity, N-nitrosodiethylamine (NDEA